1. Home
  2. MYGN vs OFG Comparison

MYGN vs OFG Comparison

Compare MYGN & OFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYGN
  • OFG
  • Stock Information
  • Founded
  • MYGN 1991
  • OFG 1964
  • Country
  • MYGN United States
  • OFG United States
  • Employees
  • MYGN N/A
  • OFG N/A
  • Industry
  • MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • OFG Major Banks
  • Sector
  • MYGN Health Care
  • OFG Finance
  • Exchange
  • MYGN Nasdaq
  • OFG Nasdaq
  • Market Cap
  • MYGN 2.0B
  • OFG 2.1B
  • IPO Year
  • MYGN 1995
  • OFG N/A
  • Fundamental
  • Price
  • MYGN $17.99
  • OFG $40.80
  • Analyst Decision
  • MYGN Buy
  • OFG Buy
  • Analyst Count
  • MYGN 12
  • OFG 2
  • Target Price
  • MYGN $28.18
  • OFG $47.50
  • AVG Volume (30 Days)
  • MYGN 678.6K
  • OFG 291.0K
  • Earning Date
  • MYGN 11-07-2024
  • OFG 10-16-2024
  • Dividend Yield
  • MYGN N/A
  • OFG 2.46%
  • EPS Growth
  • MYGN N/A
  • OFG 8.35
  • EPS
  • MYGN N/A
  • OFG 4.13
  • Revenue
  • MYGN $802,200,000.00
  • OFG $639,464,000.00
  • Revenue This Year
  • MYGN $13.84
  • OFG N/A
  • Revenue Next Year
  • MYGN $9.57
  • OFG $3.16
  • P/E Ratio
  • MYGN N/A
  • OFG $9.75
  • Revenue Growth
  • MYGN 14.78
  • OFG 2.17
  • 52 Week Low
  • MYGN $16.00
  • OFG $30.53
  • 52 Week High
  • MYGN $29.30
  • OFG $47.57
  • Technical
  • Relative Strength Index (RSI)
  • MYGN 22.28
  • OFG 45.40
  • Support Level
  • MYGN $21.57
  • OFG $40.11
  • Resistance Level
  • MYGN $22.92
  • OFG $41.34
  • Average True Range (ATR)
  • MYGN 1.00
  • OFG 1.06
  • MACD
  • MYGN -0.25
  • OFG 0.02
  • Stochastic Oscillator
  • MYGN 13.47
  • OFG 26.76

About MYGN Myriad Genetics Inc.

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.

About OFG OFG Bancorp

OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. It provides services in the region of Puerto Rico.

Share on Social Networks: